Free Trial

Bluejay Diagnostics (BJDX) Competitors

Bluejay Diagnostics logo
$1.57 -0.05 (-3.09%)
Closing price 04:00 PM Eastern
Extended Trading
$1.58 +0.00 (+0.32%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BJDX vs. CODX, SSKN, LFWD, TNON, ICU, POAI, SINT, LUCY, STRR, and STSS

Should you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Co-Diagnostics (CODX), Strata Skin Sciences (SSKN), Lifeward (LFWD), Tenon Medical (TNON), SeaStar Medical (ICU), Predictive Oncology (POAI), SINTX TECHNOLOGIES (SINT), Innovative Eyewear (LUCY), Star Equity (STRR), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry.

Bluejay Diagnostics vs. Its Competitors

Co-Diagnostics (NASDAQ:CODX) and Bluejay Diagnostics (NASDAQ:BJDX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.

15.0% of Co-Diagnostics shares are held by institutional investors. Comparatively, 18.5% of Bluejay Diagnostics shares are held by institutional investors. 8.4% of Co-Diagnostics shares are held by insiders. Comparatively, 0.1% of Bluejay Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Co-Diagnostics and Co-Diagnostics both had 1 articles in the media. Co-Diagnostics' average media sentiment score of 0.00 equaled Bluejay Diagnostics'average media sentiment score.

Company Overall Sentiment
Co-Diagnostics Neutral
Bluejay Diagnostics Neutral

Co-Diagnostics presently has a consensus target price of $5.50, indicating a potential upside of 1,835.94%. Given Co-Diagnostics' stronger consensus rating and higher probable upside, equities analysts clearly believe Co-Diagnostics is more favorable than Bluejay Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Co-Diagnostics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Bluejay Diagnostics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Bluejay Diagnostics has a net margin of 0.00% compared to Co-Diagnostics' net margin of -1,025.45%. Co-Diagnostics' return on equity of -60.16% beat Bluejay Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Co-Diagnostics-1,025.45% -60.16% -52.69%
Bluejay Diagnostics N/A -322.46%-262.96%

Bluejay Diagnostics has lower revenue, but higher earnings than Co-Diagnostics. Co-Diagnostics is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Co-Diagnostics$3.91M2.44-$37.64M-$1.17-0.24
Bluejay Diagnostics$250K9.36-$7.72M-$379.740.00

Co-Diagnostics has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, Bluejay Diagnostics has a beta of 0.47, suggesting that its share price is 53% less volatile than the S&P 500.

Summary

Co-Diagnostics beats Bluejay Diagnostics on 10 of the 15 factors compared between the two stocks.

Get Bluejay Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BJDX vs. The Competition

MetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.42M$6.86B$5.72B$9.48B
Dividend YieldN/A1.27%4.59%3.98%
P/E Ratio0.0025.4327.9219.95
Price / Sales9.3650.23441.30102.64
Price / CashN/A20.6736.5558.97
Price / Book0.154.728.635.90
Net Income-$7.72M$176.14M$3.24B$258.42M
7 Day Performance-2.48%1.68%3.22%1.94%
1 Month Performance-1.88%3.77%10.72%12.02%
1 Year Performance-94.40%6.45%34.94%20.81%

Bluejay Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BJDX
Bluejay Diagnostics
0.4971 of 5 stars
$1.57
-3.1%
N/A-94.6%$2.42M$250K0.009
CODX
Co-Diagnostics
3.8805 of 5 stars
$0.28
+1.4%
$5.50
+1,840.7%
-77.4%$9.38M$3.91M-0.24100High Trading Volume
SSKN
Strata Skin Sciences
2.6978 of 5 stars
$2.21
+0.5%
$6.00
+171.5%
-39.4%$9.18M$33.56M0.00120
LFWD
Lifeward
1.9929 of 5 stars
$0.74
+1.1%
$9.00
+1,119.5%
-79.2%$8.04M$25.41M-0.2460
TNON
Tenon Medical
1.5895 of 5 stars
$1.14
+8.1%
$4.67
+309.4%
+69.2%$8.01M$3.28M-0.048
ICU
SeaStar Medical
0.2453 of 5 stars
$0.68
-4.1%
N/A-90.1%$7.95M$140K-0.202
POAI
Predictive Oncology
2.4996 of 5 stars
$0.79
-0.6%
$3.00
+282.1%
-29.5%$7.06M$1.62M-0.2630
SINT
SINTX TECHNOLOGIES
2.9855 of 5 stars
$2.78
+0.4%
$28.00
+907.2%
-46.2%$6.95M$2.89M-0.0540
LUCY
Innovative Eyewear
0.0899 of 5 stars
$2.18
+3.8%
N/A-54.7%$6.50M$1.64M-0.559Gap Up
STRR
Star Equity
3.0357 of 5 stars
$2.04
+2.9%
$5.00
+144.8%
-55.4%$6.37M$53.36M-0.60460
STSS
Sharps Technology
1.0481 of 5 stars
$6.31
+9.4%
N/AN/A$5.88MN/A0.003

Related Companies and Tools


This page (NASDAQ:BJDX) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners